Amgen trial to evaluate cardiovascular impact of anemia treatment in CKD patients with type 2 diabetes

被引：0
|
作者：
不详
机构：
来源：
DIALYSIS & TRANSPLANTATION | 2004年 / 33卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：756 / 756
页数：1
相关论文
共 50 条
  • [41] Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial
    Jhund, Pardeep S.
    McMurray, John J. V.
    Chaturvedi, Nish
    Brunel, Patrick
    Desai, Akshay S.
    Finn, Peter V.
    Haffner, Steven M.
    Solomon, Scott D.
    Weinrauch, Larry A.
    Claggett, Brian L.
    Pfeffer, Marc A.
    EUROPEAN HEART JOURNAL, 2015, 36 (36) : 2463 - 2469
  • [42] Pioglitazone and Cardiovascular Events in Type 2 Diabetes: Effects of Pioglitazone on Cardiovascular Outcomes in Japanese Patients with Type 2 Diabetes in Higashi-Saitama (EPOCH Trial)
    Aso, Yoshimasa
    Takebayashi, Kohzo
    Inukai, Toshihiko
    Katsumori, Kozo
    Owada, Kazuhiro
    Nakamura, Tsukasa
    Naito, Takeshi
    Itabashi, Hideo
    Morita, Koichi
    Sekine, Makio
    Takahashi, Kiyoko
    Miyano, Hiroshi
    Takai, Takaji
    DIABETES, 2011, 60 : A557 - A557
  • [43] Cardiovascular risk in patients with type 2 diabetes
    Parmar, M
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (09) : 1160 - 1160
  • [44] Cardiovascular disease in patients with type 2 diabetes
    Jeon, Ja Young
    Kim, Dae Jung
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (04) : 614 - 616
  • [45] Dapagliflozin treatment for type 2 diabetes mellitus patients with a history of cardiovascular disease
    Leiter, L.
    Cefalu, W.
    DeBruin, T.
    Gause-Nilsson, I.
    Sugg, J.
    Parikh, S.
    DIABETOLOGIA, 2012, 55 : S310 - S311
  • [46] EU Approval granted for Finerenone for the Treatment of CKD in Type 2 Diabetes
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2022, 31 (02): : 132 - 132
  • [47] Impact of Type 2 Diabetes Mellitus and CKD on Bone Mineral Density in Elderly Patients with Hip Fractures
    Roy, Debajyoti M.
    Ng, Chee Yong
    Vasudevan, Vyjayanti
    Koduri, Sreekanth
    Yeon Wenxiang
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [48] Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes
    Hartweg, Janine
    Farmer, Andrew J.
    Holman, Rury R.
    Neil, Andrew
    CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (01) : 30 - 38
  • [49] Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
    Nathan, DM
    Cleary, PA
    Backlund, JYC
    Genuth, SM
    Lachin, JM
    Orchard, TJ
    Raskin, P
    Zinman, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25): : 2643 - 2653
  • [50] Impact of type 2 diabetes and cardiovascular disease on initial response (6-weeks) to sibutramine treatment - An nalysis of the sibutramine cardiovascular outcomes (SCOUT) trial
    Van Gaal, Luc
    Caterson, Ian
    Coutinho, Walmir
    Finer, Nick
    Maggioni, Aldo
    Sharma, Arya
    Torp-Pedersen, Christian
    James, W. Philip T.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S168 - S168
12345